Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125547134 | 12554713 | 4 | F | 20160715 | 20160713 | 20160726 | EXP | PHJP2016JP019640 | SANDOZ | 16.00 | YR | M | Y | 0.00000 | 20160726 | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125547134 | 12554713 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK | U | 0 | CAPSULE | ||||||||
| 125547134 | 12554713 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125547134 | 12554713 | 3 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125547134 | 12554713 | 4 | C | PREDNISOLON | PREDNISOLONE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125547134 | 12554713 | 1 | Nephrotic syndrome |
| 125547134 | 12554713 | 2 | Product used for unknown indication |
| 125547134 | 12554713 | 3 | Product used for unknown indication |
| 125547134 | 12554713 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125547134 | 12554713 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125547134 | 12554713 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |